5 Pharmaceutical Trends Changing Temperature Control Requirements

5 Pharmaceutical Trends Changing Temperature Control Requirements

Pharmaceutical development is becoming more complex at nearly every stage. Researchers are moving reactions into continuous processes, scaling cell and gene therapies, developing more sophisticated biologics, refining lipid nanoparticle formulations, and controlling API crystallization with greater precision. Each advance leaves less room for variation during process development.

Temperature can influence reaction kinetics, formulation stability, crystal formation, biological processes, and consistency as a process moves from the bench toward larger-scale production.

That makes precise liquid temperature control increasingly important in pharmaceutical R&D and process development.

Here are five trends shaping those requirements:

1. Continuous Manufacturing and Flow Chemistry
2. Scaling Cell and Gene Therapy Manufacturing
3. Advanced Biologics and Antibody-Drug Conjugates
4. mRNA and Lipid Nanoparticle Formulation
5. API Crystallization and Particle Engineering

1. Continuous Manufacturing and Flow Chemistry

Pharmaceutical manufacturers are moving beyond traditional batch processing toward continuous manufacturing, where materials move through connected process steps with less interruption.

Flow chemistry is part of this shift, particularly in API development and chemical synthesis. In batch processing, a larger volume is heated or cooled in a vessel and held at the required temperature. In flow chemistry, smaller volumes move continuously through narrow channels or reactors, creating a higher surface-area-to-volume ratio and faster heat transfer.

That changes the demands on temperature control. Rather than bringing an entire batch to temperature, a flow process must maintain precise conditions as material moves through the reactor. Temperature also works closely with flow rate and pressure, so rapid response and consistent heat removal can affect reaction performance.

A review of industrial batch and flow processing notes the improved heat-transfer characteristics of flow reactors, while a JACS Au review of continuous flow synthesis highlights precise temperature control as a key advantage for fast, exothermic, and temperature-sensitive reactions.

Temperature Control Solutions and Product Recommendations for Continuous Manufacturing and Flow Chemistry:

2. Scaling Cell and Gene Therapy Manufacturing

Cell and gene therapy manufacturing is moving from highly manual, open processes toward closed, automated systems built for greater consistency and scale. A 2025 review in the Journal of Controlled Release points to automation as a way to improve scalability and quality while reducing operator error and contamination risk.

Living cells respond to changes in temperature, pH, dissolved oxygen, and mixing conditions. These variables can affect cell growth, metabolism, differentiation, and product quality. As manufacturers standardize and automate production, conditions need to be reproduced consistently from one run and system to the next.

That puts more emphasis on temperature as a controlled and documented process parameter. A 2026 review in Cytotherapy identifies standardization and automation as key to improving reproducibility and scalability.

For teams moving beyond the development bench, temperature control should be evaluated as part of that transition rather than carried forward unchanged.

Temperature Control Solutions and Product Recommendations for Cell and Gene Therapy Manufacturing:

3. Advanced Biologics and Antibody-Drug Conjugates

Pharmaceutical development is moving toward more complex biologics, including bispecific antibodies and antibody-drug conjugates (ADCs). These therapies introduce more sensitive manufacturing steps and tighter process windows.

Temperature can affect protein stability, aggregation, reaction rates, and conjugation consistency. For ADCs, control is especially important during the steps that attach the drug payload to the antibody, where process conditions can influence product uniformity and stability.

A 2026 review of ADC manufacturing strategies highlights the move toward more controlled, site-specific conjugation approaches designed to improve consistency and manufacturability.

For process development teams, that means evaluating whether existing temperature control can deliver the stability, responsiveness, and repeatability these processes require.

Temperature Control Solutions and Product Recommendations for Advanced Biologics and Antibody-Drug Conjugates:

4. mRNA and Lipid Nanoparticle Formulation

mRNA therapeutics are expanding beyond infectious disease vaccines into cancer treatment, protein replacement, and other genetic medicines. A 2026 review in Trends in Biotechnology points to formulation, scale-up, continuous manufacturing, and lipid nanoparticle design as key areas shaping the next generation of mRNA therapeutics.

Lipid nanoparticles form when an mRNA-containing aqueous phase is rapidly mixed with lipids in an organic phase. The process depends on tightly controlled conditions, including flow rate, mixing, concentration, pH, and temperature. A 2025 review in the International Journal of Pharmaceutics highlights the importance of these parameters during scale-up.

Temperature can influence lipid behavior, particle formation, mRNA stability, and degradation. A 2026 study on mRNA-LNP stability specifically examined temperature as a factor affecting formulation stability.

As mRNA-LNP platforms expand into more applications and larger-scale production, temperature control becomes part of maintaining consistent formulation conditions from development through scale-up.

Temperature Control Solutions and Product Recommendations for mRNA and Lipid Nanoparticle Formulation:

5. API Crystallization and Particle Engineering

Crystallization is playing a larger role in pharmaceutical process development as manufacturers focus on the physical properties of the API, not just purity. Crystal form, particle size, and particle-size distribution can affect solubility, bioavailability, filtration, drying, and downstream manufacturing. A 2026 review of crystallization and particle engineering describes these steps as central to API performance and manufacturability.

Temperature is one of the main tools used to control how crystals nucleate and grow. Cooling profiles can influence particle size and distribution, while temperature changes can affect which polymorphic form develops. A review in Organic Process Research & Development identifies cooling profiles, seeding, and mixing as key variables in producing API particles within specification.

As crystallization becomes more deliberately engineered, temperature control needs to support precise cooling profiles and repeatable conditions from development through scale-up.

Frequently Asked Questions about Temperature Control and Pharmaceutical R&D

Why is precise temperature control important in pharmaceutical development?
Temperature can affect reaction rates, product stability, cell behavior, crystallization, and formulation consistency.

How does continuous manufacturing change temperature control requirements?
Continuous systems must maintain stable thermal conditions while material moves through the process, increasing the importance of fast response and consistent heat transfer.

Why does temperature control matter during pharmaceutical scale-up?
Larger or more automated processes can behave differently from bench-scale systems. Consistent temperature control helps preserve process conditions as production scales.

How does temperature affect API crystallization?
Temperature and cooling profiles influence nucleation, crystal growth, particle size, and polymorphic form.

Why should pharmaceutical labs reevaluate existing temperature control equipment?
New processes may require tighter stability, faster heating or cooling, broader temperature ranges, or better process documentation.

Conclusion

As pharmaceutical processes become more continuous, automated, and complex, temperature control requirements are changing with them. Reviewing those requirements can support consistency, scale-up, and new applications.

JULABO USA works with pharmaceutical laboratories and process development teams to identify temperature control solutions for demanding applications.

Explore JULABO USA’s pharmaceutical temperature control solutions or contact us to discuss your application needs.